Navigation Links
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
Date:11/1/2007

- Albuferon Phase 3 trials complete enrollment two months ahead of schedule

- - Progress continues on LymphoStat-B, ABthrax and TRAIL receptor antibody

programs -

- 2007 net cash burn on track for $145-165 million -

ROCKVILLE, Md., Nov. 1 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced financial results and key developments for the quarter ended September 30, 2007.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"We are making good progress with our Phase 3 clinical trials of Albuferon(R) in patients with chronic hepatitis C and LymphoStat-B(R) in patients with lupus," said H. Thomas Watkins, President and Chief Executive Officer. "We completed enrollment of both of our Albuferon Phase 3 trials ahead of schedule. Enrollment of LymphoStat-B Phase 3 trials is progressing, and we expect to complete enrollment in 2008. We have met all milestones to date under our $165 million contract to supply ABthrax(TM) to the U.S. Strategic National Stockpile. Our cash position remains strong, and we are moving steadily toward commercialization."

HGS reported that net cash burn for the nine months ended September 30, 2007 totaled $81.2 million, net of $87.5 million in milestone payments received from Novartis.

"Even with the early full enrollment of the two Albuferon Phase 3 trials, we continue to expect net cash burn for 2007 in the range of $145-165 million," said Tim Barabe, Senior Vice President and Chief Financial Officer. "Our focus on controlling net cash burn is an important ongoing
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/11/2014)... EPFL and the University of  Geneva ... John P. Donoghue . The American neuroscientist is ... . The new Wyss Center for Bio- ... Geneva , has named as its director one ... Donoghue , founder of Brown University,s Institute for Brain ...
(Date:7/10/2014)... Women in the West African ... additional family planning option. Sayana® Press has the ... levels of the health system and in communities ... used contraceptive—Pfizer’s Depo-Provera® (depot medroxyprogesterone acetate)—with the BD ... first of four African countries expected to begin ...
(Date:7/10/2014)... 2014 Terascala, the industry leader in ... Swahn, a former vice president of product management for ... president of marketing. Terascala’s software when combined with leading ... the highest performance and most reliable solutions for processing ... Terascala’s channel expansion and broaden its product portfolio. His ...
(Date:7/10/2014)... Montreal, QC (PRWEB) July 10, 2014 ... comfort and convenience. This rejuvenating device now comes with a ... that develops over time. , The new cup is thinner ... This design works to target rough, thin and uneven surfaces ... original firm cup for a stimulating treatment on areas such ...
Breaking Biology Technology:John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 2John P. Donoghue is Taking the Lead at the Wyss Center and is Appointed Professor at EPFL and University of Geneva 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 2Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 3Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 4Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 5Injectable Contraceptive Launched in Burkina Faso to Expand Choice and Address Unmet Need 6Terascala Expands Executive Team 2Terascala Expands Executive Team 3Introducing a New Bonus Treatment Cup for EvoDerma’s NOOME Anti-Aging Motion 2
... today announced that three Wisconsin businesses will receive funding ... Technology Matching Grant (TMG) and Technology Venture Fund (TVF) ... Quintessence Biosciences, Inc ., is a Madison ... of novel protein-based therapeutics for a variety of disease ...
... 2005 as the Year of the Woman Entrepreneur in ... , ,At last weeks Wisconsin Entrepreneurs Conference in ... with words of advice for everyone on starting or ... Milwaukee native who launched USA Networks; Nancye Miller, CEO ...
... - Leaders of Milwaukee, Racine, and Waukesha counties ... to the expansion of the Center for Advanced ... three counties is intended to increase the number of ... southeastern Wisconsin, in order to keep area innovations in ...
Cached Biology Technology:Women entrepreneurs are finding ways to succeed in Wisconsin and beyond 2Women entrepreneurs are finding ways to succeed in Wisconsin and beyond 3Southeastern Wisconsin Technology Collaboration 2Southeastern Wisconsin Technology Collaboration 3Southeastern Wisconsin Technology Collaboration 4
(Date:7/11/2014)... Researchers have pioneered a revolutionary new way to ... Virtual Finger, allows scientists to move through digital ... using the flat surface of their computer screens. ... orders of magnitude more efficient, saving time, money ... areas of experimental biology. The software and its ...
(Date:7/11/2014)... In addition to the hippocampus, the marginal division ... and memory. What is the impact degree of ... learning and memory function? Yan Yu and his ... China found, using immunofluorescence staining, that substance P ... hippocampus and striatal marginal division of normal rats. ...
(Date:7/11/2014)... -- Research and Markets has announced the ... Industry Analysis Size Share Growth Trends and Forecast to ... http://photos.prnewswire.com/prnh/20130307/600769 The rising number ... for high level security in both private and public ... username and passwords, tokens etc. are vulnerable to attacks. ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2International Biometrics Technology Market - Industry Analysis Size Share Growth Trends and Forecast to 2019 2
... HOBOKEN, N.J. The Center for Science Writings at Stevens ... Versus Selfishness Among ,Wolf Birds," a talk by Bernd Heinrich, ... in the Babbio Center, Room 122, from 4 p.m. to ... Heinrich "not just a great naturalist writer; he,s a great ...
... Walter is one good gumshoe. The University of Alberta medical ... to glaucoma. , Glaucoma is a leading cause of blindness ... brain from understanding what patients see. Scientists have long suspected ... to figure out what the gene does and why some ...
... CA (March 20, 2009) A rigorous environmental cleaning ... Staphylococcus aureus (MRSA) and other multidrug-resistant organisms ... a new study released today at the annual ... America (SHEA). Researchers found that following an ...
Cached Biology News:Genetic sleuth solves glaucoma mystery 2Environmental cleaning intervention reduces transmission of multidrug-resistant organisms in ICUs 2
Request Info...
... include: ,ICC and IHC Protocol Development ... ,Antibody Screenings in Animal or Human ... of Cells and Tissues ,Peroxidase, Alkaline ... Fluorescent, or Electron Microscopy ,Protein Localization ...
Request Info...
Request Info...
Biology Products: